Adding creatinine to routine pregnancy tests: a decision tree for calculating the cost of identifying patients with CKD in pregnancy
Authors:
- Giorgina Barbara PiccoliGiorgina Barbara Piccoli
- Massimo TorreggianiMassimo Torreggiani
- Kidney and Pregnancy Study Group of the Italian Society of NephrologyKNKidney and Pregnancy Study Group of the Italian Society of Nephrology
- Domenico SantoroDSDomenico Santoro
- Gabriella MoroniGMGabriella Moroni
- Linda GammaroLGLinda Gammaro
Open Access
- 3 March 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 38 (1) , 148-157
Abstract
Background: Even in its early stages, chronic kidney disease (CKD) is associated with adverse pregnancy outcomes. The current guidelines for pregnancy management suggest identifying risk factors for adverse outcomes but do not mention kidney diseases. Since CKD is often asymptomatic, pregnancy offers a valuable opportunity for diagnosis. The present analysis attempts to quantify the cost of adding serum creatinine to prenatal screening and monitoring tests. Methods: The decision tree we built takes several screening scenarios (before, during and after pregnancy) into consideration, following the hypothesis that while 1:750 pregnant women are affected by stage 4–5 CKD and 1:375 by stage 3B, only 50% of CKD cases are known. Prevalence of abortions/miscarriages was calculated at 30%; compliance with tests was hypothesized at 50% pre- and post-pregnancy and 90% during pregnancy (30% for miscarriages); the cost of serum creatinine (production cost) was set at 0.20 euros. A downloadable calculator, which makes it possible to adapt these figures to other settings, is available. Results: The cost per detected CKD case ranged from 111 euros (one test during pregnancy, diagnostic yield 64.8%) to 281.90 euros (one test per trimester, plus one post-pregnancy or miscarriage, diagnostic yield 87.7%). The best policy is identified as one test pre-, one during and one post-pregnancy (191.80 euros, diagnostic yield 89.4%). Conclusions: This study suggests the feasibility of early CKD diagnosis in pregnancy by adding serum creatinine to routinely performed prenatal tests and offers cost estimates for further discussion.Keywords
Funding Information
- Centre Hospitalier Le Mans
This publication has 55 references indexed in Scilit:
- Risk of Adverse Pregnancy Outcomes in Women with CKDJournal of the American Society of Nephrology, 2015
- GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled TrialsAmerican Journal of Kidney Diseases, 2014
- Early referral to specialist nephrology services for preventing the progression to end-stage kidney diseaseCochrane Database of Systematic Reviews, 2014
- Reimbursement of DialysisJournal of the American Society of Nephrology, 2012
- Longitudinal Progression Trajectory of GFR Among Patients With CKDAmerican Journal of Kidney Diseases, 2012
- Pregnancy Outcomes in Women with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Association between time of referral and survival in the first year of dialysis in diabetics and the elderlyNephrology Dialysis Transplantation, 2010
- Chronic kidney disease in pregnancyBMJ, 2008
- Errors in clinical laboratories or errors in laboratory medicine?Clinical Chemistry and Laboratory Medicine (CCLM), 2006
- Methods in health service research: Handling uncertainty in economic evaluations of healthcare interventionsBMJ, 1999